Next-generation Bioanalytical instrument for Biologics Drug Discovery

Determination of binding kinetics is an imperative and laborious phase in biological drug discovery. The WAVEsystem, a Creoptix technology, was developed with researchers in mind. Based on the GCI detection principle, it provides outstanding sensitivity, reducing sample consumption and mass transfer hindrances. 

Combining GCI technology with our no-clog WAVEchips and waveRAPID (a new method of measuring kinetics from single concentration), the WAVEsystem will increase your throughput and optimize your workflow. 

What will you learn?

  • Introduction of our new regenerable Streptavidin (RST) WAVEchip
  • How to resolve Complex Binding Kinetics between Adeno-Associated Virus (AAV) and Antibodies
  • How to optimize Workflows by Measuring the kinetics of Biologics in 90% Serum

Determination of binding kinetics is an imperative and laborious phase in biological drug discovery. The WAVEsystem, a Creoptix technology, was developed with researchers in mind. Based on the GCI detection principle, it provides outstanding sensitivity, reducing sample consumption and mass transfer hindrances. 

Combining GCI technology with our no-clog WAVEchips and waveRAPID (a new method of measuring kinetics from single concentration), the WAVEsystem will increase your throughput and optimize your workflow. 

What will you learn?

  • Introduction of our new regenerable Streptavidin (RST) WAVEchip
  • How to resolve Complex Binding Kinetics between Adeno-Associated Virus (AAV) and Antibodies
  • How to optimize Workflows by Measuring the kinetics of Biologics in 90% Serum

Login

Not registered yet? Create an account